Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.5M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
2.89M
-
Shares change
-
+2.63M
-
Total reported value, excl. options
-
$11.5M
-
Value change
-
+$10.6M
-
Number of buys
-
13
-
Number of sells
-
-7
-
Price
-
$4.06
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q1 2024
32 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q1 2024.
iBio, Inc. - Common Stock (IBIO) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.89M shares
of 22.5M outstanding shares and own 12.84% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (680K shares), ADAR1 Capital Management, LLC (600K shares), Ikarian Capital, LLC (600K shares), Lynx1 Capital Management LP (600K shares), ARMISTICE CAPITAL, LLC (351K shares), RENAISSANCE TECHNOLOGIES LLC (15.9K shares), SABBY MANAGEMENT, LLC (14K shares), FNY Investment Advisers, LLC (9K shares), BlackRock Inc. (5.82K shares), and Tower Research Capital LLC (TRC) (5.6K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.